Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Onundarson PT"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 30
Tytuł:
Sequence variant affects GCSAML splicing, mast cell specific proteins, and risk of urticaria.
Autorzy:
Kristjansson RP; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Oskarsson GR; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Skuladottir A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Oddsson A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Rognvaldsson S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Sveinbjornsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Lund SH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jensson BO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Styrmisdottir EL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ferkingstad E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Eldjarn GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Beyter D; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Kristmundsdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
Juliusson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Fridriksdottir R; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Arnadottir GA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Katrinardottir H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Snorradottir MH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Tragante V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Stefansdottir L; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ivarsdottir EV; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Bjornsdottir G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Halldorsson BV; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
Thorleifsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ludviksson BR; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Immunology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Onundarson PT; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Laboratory Hematology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Saevarsdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Rheumatology Unit, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.; Department of Medicine, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Melsted P; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Norddahl GL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Bjornsdottir US; Department of Medicine, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.; The Medical Center Mjodd, Reykjavik, Iceland.
Olafsdottir T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Gudbjartsson DF; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Thorsteinsdottir U; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Jonsdottir I; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Sulem P; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .
Stefansson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2023 Jul 10; Vol. 6 (1), pp. 703. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Genome-Wide Association Study*
Urticaria*/genetics
Humans ; Mast Cells ; RNA Splicing ; Proteome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Platelet function testing: Current practice among clinical centres in Northern Europe.
Autorzy:
Szanto T; Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, Helsinki University, Helsinki, Finland.
Zetterberg E; Department of Translational Medicine & Centre for Thrombosis and Haemostasis, Lund University, Malmö, Sweden.
Ramström S; Department of Clinical Chemistry and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.; School of Medical Sciences, Örebro University, Örebro, Sweden.
Leinøe EB; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Holme PA; Department of Haematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Antovic JP; Coagulation Research, Institute for Molecular Medicine and Surgery, Karolinska Institute & Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
Holmström M; Department of Health and Department of Acute Internal Medicine and Geriatrics, Medicine and Caring Sciences Linköping University, Linköping, Sweden.
Onundarson PT; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Pikta M; Laboratory, North Estonia Medical Centre, Tallinn, Estonia.
Vaide I; Department of Hemato-Oncology, University of Tartu, Institute of Clinical Medicine, Tartu, Estonia.
Olsson A; Region Västra Götaland, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Magnusson M; Department of Haematology and Coagulation Disorders, Sahlgrenska University Hospital, Gothenburg, Sweden.
Kärkkäinen S; Hemostasis and Platelet Laboratory, Fimlab Laboratoriot, Tampere, Finland.
Bitar M; Department of Laboratory Medicine, Clinical Chemistry, Faculty of Medicine and Health, Örebro University Hospital, Örebro, Sweden.
Poulsen LH; Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus, Denmark.
Lassila R; Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, Helsinki University, Helsinki, Finland.
Pokaż więcej
Corporate Authors:
Nordic Haemophilia Council; Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. 642-648. Date of Electronic Publication: 2022 May 05.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Platelet Disorders*/diagnosis
von Willebrand Diseases*/diagnosis
Blood Platelets ; Europe ; Hemorrhage/diagnosis ; Humans ; Platelet Function Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic architecture of band neutrophil fraction in Iceland.
Autorzy:
Oskarsson GR; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Magnusson MK; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. .
Oddsson A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jensson BO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Fridriksdottir R; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Arnadottir GA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Katrinardottir H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Rognvaldsson S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Sveinbjornsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ivarsdottir EV; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Stefansdottir L; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ferkingstad E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Norland K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Tragante V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Saemundsdottir J; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jonasdottir A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jonasdottir A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Sigurjonsdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Petursdottir KO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Davidsson OB; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Rafnar T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Holm H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Olafsson I; Department of Clinical Biochemistry, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Onundarson PT; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Laboratory Hematology, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Vidarsson B; Department of Laboratory Hematology, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.; The Laboratory in Mjodd, RAM, Reykjavik, Iceland.
Sigurdardottir O; Department of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
Masson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gudbjartsson DF; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Jonsdottir I; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Immunology of Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Norddahl GL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Thorsteinsdottir U; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Sulem P; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Stefansson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Jun 01; Vol. 5 (1), pp. 525. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Pelger-Huet Anomaly*/genetics
Genome-Wide Association Study ; Granulocytes/metabolism ; Humans ; Iceland ; Neutrophils/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article.
Autorzy:
Onundarson PT; Central Laboratory/Hematology, Landspitali National University Hospital of Iceland and University of Iceland Faculty of Medicine, Hringbraut, 101 Reykjavik, Reykjavik, Iceland. .
Palsson R; Nephrology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Witt DM; Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA.
Gudmundsdottir BR; Central Laboratory/Hematology, Landspitali National University Hospital of Iceland , Reykjavik, Iceland.
Pokaż więcej
Źródło:
Thrombosis journal [Thromb J] 2021 Oct 15; Vol. 19 (1), pp. 72. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic variants associated with platelet count are predictive of human disease and physiological markers.
Autorzy:
Mikaelsdottir E; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland. .
Thorleifsson G; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Stefansdottir L; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Halldorsson G; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Sigurdsson JK; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Lund SH; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Tragante V; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Melsted P; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Rognvaldsson S; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Norland K; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Helgadottir A; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Magnusson MK; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
Ragnarsson GB; Department of Oncology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Kristinsson SY; Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.; Department of Hematology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Reykdal S; Department of Hematology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Vidarsson B; Department of Hematology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Gudmundsdottir IJ; Department of Cardiology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Olafsson I; Department of Clinical Biochemistry, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Onundarson PT; Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.; Laboratory Hematology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Sigurdardottir O; Department of Clinical Biochemistry, Akureyri Hospital, 600, Akureyri, Iceland.
Sigurdsson EL; Development Centre for the Primary Care, 109, Reykjavik, Iceland.
Grondal G; Department of Rheumatology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Geirsson AJ; Department of Rheumatology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Geirsson G; Department of Urology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Gudmundsson J; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Holm H; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Saevarsdottir S; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.; Department of Rheumatology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Jonsdottir I; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
Thorgeirsson G; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.; Department of Cardiology, Landspitali-University Hospital, 101, Reykjavik, Iceland.
Gudbjartsson DF; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Thorsteinsdottir U; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
Rafnar T; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland.
Stefansson K; deCODE Genetics/Amgen, Sturlugata 8, 101, Reykjavik, Iceland. .; Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2021 Sep 27; Vol. 4 (1), pp. 1132. Date of Electronic Publication: 2021 Sep 27.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Genetic Variation*
Phenotype*
Platelet Count*
Quantitative Trait Loci*
Biomarkers/*analysis
Female ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis.
Autorzy:
Bell S; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Rigas AS; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Magnusson MK; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. .
Ferkingstad E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Allara E; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Bjornsdottir G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ramond A; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Sørensen E; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Paul DS; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Burgdorf KS; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Eggertsson HP; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Howson JMM; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Thørner LW; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Kristmundsdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Astle WJ; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Sigurdsson JK; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Vuckovic D; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Dinh KM; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Tragante V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Surendran P; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Rutherford Fund Fellow, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Pedersen OB; Department of Clinical Immunology, Næstved Hospital, Næstved, Denmark.
Vidarsson B; The Laboratory in Mjodd, RAM, Reykjavik, Iceland.
Jiang T; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Paarup HM; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Onundarson PT; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Laboratory Hematology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Akbari P; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Nielsen KR; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Lund SH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Juliusson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Magnusson MI; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Frigge ML; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Oddsson A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Olafsson I; Department of Clinical Biochemistry, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Kaptoge S; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Hjalgrim H; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Runarsson G; The Laboratory in Mjodd, RAM, Reykjavik, Iceland.
Wood AM; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Jonsdottir I; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Hansen TF; Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, Glostrup, Denmark.; Institute of Biological Psychiatry, Copenhagen University Hospital MHC Sct. Hans, Roskilde, Denmark.; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Sigurdardottir O; Department of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
Stefansson H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Rye D; Department of Neurology and Program in Sleep, Emory University School of Medicine, Atlanta, GA, USA.
Peters JE; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Westergaard D; Translational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Holm H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Soranzo N; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.
Banasik K; Translational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Thorleifsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ouwehand WH; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; UK National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.
Thorsteinsdottir U; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Roberts DJ; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; Radcliffe Department of Medicine and National Health Service Blood and Transplant, John Radcliffe Hospital, Oxford, UK.; UK National Health Service Blood and Transplant, John Radcliffe Hospital, Oxford, OX3 9BQ, UK.
Sulem P; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Butterworth AS; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Gudbjartsson DF; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Danesh J; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Brunak S; Translational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Di Angelantonio E; The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics at the University of Cambridge, University of Cambridge, Cambridge, UK. .; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. .; UK National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK. .
Ullum H; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark. .
Stefansson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. .
Pokaż więcej
Corporate Authors:
DBDS Genomic Consortium
Źródło:
Communications biology [Commun Biol] 2021 Feb 03; Vol. 4 (1), pp. 156. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Anemia, Iron-Deficiency*/blood
Anemia, Iron-Deficiency*/diagnosis
Anemia, Iron-Deficiency*/genetics
Genetic Loci*
Genetic Variation*
Iron*/blood
Iron Overload*/blood
Iron Overload*/diagnosis
Iron Overload*/genetics
Humans ; Biomarkers/blood ; Denmark ; Ferritins/blood ; Genome-Wide Association Study ; Genotype ; Homeostasis ; Iceland ; Phenotype ; Risk Assessment ; Risk Factors ; Transferrin/metabolism ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predicted loss and gain of function mutations in ACO1 are associated with erythropoiesis.
Autorzy:
Oskarsson GR; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Oddsson A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Magnusson MK; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Kristjansson RP; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ferkingstad E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Zink F; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Helgadottir A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ivarsdottir EV; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Arnadottir GA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jensson BO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Katrinardottir H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Sveinbjornsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Kristinsdottir AM; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Lee AL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Saemundsdottir J; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Stefansdottir L; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Sigurdsson JK; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Davidsson OB; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Benonisdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jonasdottir A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jonasdottir A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jonsson S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gudmundsson RL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Asselbergs FW; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.; Health Data Research UK and Institute of Health Informatics, University College London, London, UK.
Tragante V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Gunnarsson B; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Masson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Thorleifsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Rafnar T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Holm H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Olafsson I; Department of Clinical Biochemistry, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Onundarson PT; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Laboratory Hematology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Gudbjartsson DF; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Norddahl GL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Thorsteinsdottir U; deCODE genetics/Amgen Inc., Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Sulem P; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .
Stefansson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland. .; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2020 Apr 23; Vol. 3 (1), pp. 189. Date of Electronic Publication: 2020 Apr 23.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Gain of Function Mutation*
Loss of Function Mutation*
Erythropoiesis/*genetics
Hemoglobins/*metabolism
Iron Regulatory Protein 1/*genetics
Biomarkers/blood ; Databases, Genetic ; Genome-Wide Association Study ; Humans ; Iceland ; Iron Regulatory Protein 1/metabolism ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oral anticoagulant monitoring: Are we on the right track?
Autorzy:
Onundarson PT; Landspitali/The National University Hospital of Iceland, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Flygenring B; Landspitali/The National University Hospital of Iceland, Reykjavik, Iceland.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2019 May; Vol. 41 Suppl 1, pp. 40-48.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Atrial Fibrillation*/blood
Atrial Fibrillation*/drug therapy
Hemorrhage*/blood
Hemorrhage*/drug therapy
Venous Thromboembolism*/blood
Venous Thromboembolism*/drug therapy
Anticoagulants/*pharmacokinetics
Drug Monitoring/*methods
Vitamin K/*antagonists & inhibitors
Administration, Oral ; Anticoagulants/therapeutic use ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin.
Autorzy:
Oskarsson GR; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Kristjansson RP; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland. .
Lee AL; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Sveinbjornsson G; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Magnusson MK; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, 101, Reykjavík, Iceland.
Ivarsdottir EV; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, 101, Reykjavík, Iceland.
Benonisdottir S; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Oddsson A; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Davidsson OB; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Saemundsdottir J; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Halldorsson GH; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Arthur J; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Arnadottir GA; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Masson G; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Jensson BO; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Holm H; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Olafsson I; Department of Clinical Biochemistry, Landspítali University Hospital, 101, Reykjavik, Iceland.
Onundarson PT; Department of Laboratory Hematology, Landspítali University Hospital, 101, Reykjavik, Iceland.
Gudbjartsson DF; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, 101, Reykjavík, Iceland.
Norddahl GL; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Thorsteinsdottir U; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, 101, Reykjavík, Iceland.
Sulem P; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Stefansson K; deCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland. .; Faculty of Medicine, University of Iceland, 101, Reykjavík, Iceland. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2018 May 17; Vol. 1, pp. 49. Date of Electronic Publication: 2018 May 17 (Print Publication: 2018).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma.
Autorzy:
Smith D; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Helgason H; deCODE genetics / Amgen Inc., Reykjavík, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Sulem P; deCODE genetics / Amgen Inc., Reykjavík, Iceland.
Bjornsdottir US; Department of Medicine, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Lim AC; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Sveinbjornsson G; deCODE genetics / Amgen Inc., Reykjavík, Iceland.
Hasegawa H; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Brown M; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Ketchem RR; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Gavala M; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Garrett L; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Jonasdottir A; deCODE genetics / Amgen Inc., Reykjavík, Iceland.
Jonasdottir A; deCODE genetics / Amgen Inc., Reykjavík, Iceland.
Sigurdsson A; deCODE genetics / Amgen Inc., Reykjavík, Iceland.
Magnusson OT; deCODE genetics / Amgen Inc., Reykjavík, Iceland.
Eyjolfsson GI; The Laboratory in Mjodd, RAM, Reykjavik, Iceland.
Olafsson I; Department of Clinical Biochemistry, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Onundarson PT; Laboratory Hematology, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Sigurdardottir O; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
Gislason D; Department of Respiratory Medicine and Sleep, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Gislason T; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Respiratory Medicine and Sleep, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Ludviksson BR; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Immunology, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Ludviksdottir D; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Respiratory Medicine and Sleep, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Boezen HM; GRIAC research institute, Groningen, The Netherlands.; University Medical Center Groningen, University of Groningen, Department of Epidemiology, Groningen, The Netherlands.
Heinzmann A; Center for Pediatrics, Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Krueger M; Center for Pediatrics, Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Porsbjerg C; Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen University, Copenhagen, Denmark.
Ahluwalia TS; COPSAC (Copenhagen Prospective Studies on Asthma in Childhood), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Waage J; COPSAC (Copenhagen Prospective Studies on Asthma in Childhood), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Backer V; Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen University, Copenhagen, Denmark.
Deichmann KA; Center for Pediatrics, Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Koppelman GH; GRIAC research institute, Groningen, The Netherlands.; University Medical Center Groningen, University of Groningen, Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, Groningen, The Netherlands.
Bønnelykke K; COPSAC (Copenhagen Prospective Studies on Asthma in Childhood), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Bisgaard H; COPSAC (Copenhagen Prospective Studies on Asthma in Childhood), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Masson G; deCODE genetics / Amgen Inc., Reykjavík, Iceland.
Thorsteinsdottir U; deCODE genetics / Amgen Inc., Reykjavík, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Gudbjartsson DF; deCODE genetics / Amgen Inc., Reykjavík, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Johnston JA; Amgen Inc., Discovery Research, South San Francisco, California, United States of America.
Jonsdottir I; deCODE genetics / Amgen Inc., Reykjavík, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Immunology, Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland.
Stefansson K; deCODE genetics / Amgen Inc., Reykjavík, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2017 Mar 08; Vol. 13 (3), pp. e1006659. Date of Electronic Publication: 2017 Mar 08 (Print Publication: 2017).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Asthma/*genetics
Eosinophils/*metabolism
Interleukin-33/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alternative Splicing ; Animals ; Binding Sites ; Biological Assay ; Child ; Child, Preschool ; Denmark ; Female ; Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Heterozygote ; Humans ; Iceland ; Infant ; Infant, Newborn ; Introns ; Male ; Mice ; Mice, Transgenic ; Middle Aged ; Netherlands ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Fiix-prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin.
Autorzy:
Onundarson PT; Landspitali National University Hospital of Iceland, Reykjavik, Iceland.; University of Iceland Faculty of Medicine, Reykjavik, Iceland.
Arnar DO; Landspitali National University Hospital of Iceland, Reykjavik, Iceland.
Lund SH; University of Iceland Faculty of Medicine, Reykjavik, Iceland.
Gudmundsdottir BR; Landspitali National University Hospital of Iceland, Reykjavik, Iceland.
Francis CW; University of Rochester Medical Center, Rochester, NY, USA.
Indridason OS; Landspitali National University Hospital of Iceland, Reykjavik, Iceland.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2016 May; Vol. 38 Suppl 1, pp. 78-90.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Prothrombin Time*
Atrial Fibrillation/*therapy
Drug Monitoring/*methods
Warfarin/*therapeutic use
Atrial Fibrillation/complications ; Atrial Fibrillation/mortality ; Humans ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Vascular Diseases/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prediction of survival in patients suspected of disseminated intravascular coagulation.
Autorzy:
Hjorleifsson E; University of Iceland School of Health Sciences, Landspitali National University Hospital, Reykjavik, Iceland.
Sigurdsson MI; Department of Anaesthesiology and Intensive Care Medicine, Landspitali National University Hospital, Reykjavik, Iceland.; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Gudmundsdottir BR; Central Laboratory, Division of Laboratory Hematology and Coagulation Disorders, Landspitali National University Hospital, Reykjavik, Iceland.
Sigurdsson GH; University of Iceland School of Health Sciences, Landspitali National University Hospital, Reykjavik, Iceland.; Department of Anaesthesiology and Intensive Care Medicine, Landspitali National University Hospital, Reykjavik, Iceland.
Onundarson PT; University of Iceland School of Health Sciences, Landspitali National University Hospital, Reykjavik, Iceland.; Central Laboratory, Division of Laboratory Hematology and Coagulation Disorders, Landspitali National University Hospital, Reykjavik, Iceland.
Pokaż więcej
Źródło:
Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2015 Aug; Vol. 59 (7), pp. 870-80. Date of Electronic Publication: 2015 Apr 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disseminated Intravascular Coagulation/*mortality
Adult ; Cohort Studies ; Female ; Humans ; Iceland/epidemiology ; Male ; Prognosis ; Retrospective Studies ; Risk ; Severity of Illness Index ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms.
Autorzy:
Oddsson A; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Kristinsson SY; 1] Faculty of Medicine, University of Iceland, Reykjavik, Iceland [2] Department of Hematology, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Helgason H; 1] deCODE Genetics/Amgen Inc., Reykjavik, Iceland [2] School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Gudbjartsson DF; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Masson G; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Sigurdsson A; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Jonasdottir A; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Jonasdottir A; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Steingrimsdottir H; Department of Hematology, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Vidarsson B; Department of Hematology, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Reykdal S; Department of Hematology, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Eyjolfsson GI; The Laboratory in Mjodd, RAM, Reykjavik, Iceland.
Olafsson I; Department of Clinical Biochemistry, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Onundarson PT; 1] Faculty of Medicine, University of Iceland, Reykjavik, Iceland [2] Department of Hematology, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Runarsson G; Department of Hematology, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
Sigurdardottir O; Department of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
Kong A; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Rafnar T; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Sulem P; deCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Thorsteinsdottir U; 1] deCODE Genetics/Amgen Inc., Reykjavik, Iceland [2] Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Stefansson K; 1] deCODE Genetics/Amgen Inc., Reykjavik, Iceland [2] Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2014 Jun; Vol. 28 (6), pp. 1371-4. Date of Electronic Publication: 2014 Jan 30.
Typ publikacji:
Letter
MeSH Terms:
Genetic Predisposition to Disease*
Germ-Line Mutation/*genetics
Myeloproliferative Disorders/*genetics
Telomerase/*genetics
Humans ; Prognosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
Autorzy:
Palsson R; Department of Medicine, Duke University Medical Center , Durham, North Carolina , USA .
Vidarsson B
Gudmundsdottir BR
Larsen OH
Ingerslev J
Sorensen B
Onundarson PT
Pokaż więcej
Źródło:
Platelets [Platelets] 2014; Vol. 25 (5), pp. 357-62. Date of Electronic Publication: 2013 Aug 02.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bernard-Soulier Syndrome/*blood
Fibrinogen/*pharmacology
Adult ; Blood Coagulation/drug effects ; Female ; Hemorrhage/prevention & control ; Humans ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 30

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies